233 related articles for article (PubMed ID: 3549583)
1. Double-blind, randomized, cross-over clinical trial of metoprolol and propranolol in mild to moderate essential hypertension.
Pandhi P; Sahai J; Wahi PL; Sharma BK; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):163-5. PubMed ID: 3549583
[TBL] [Abstract][Full Text] [Related]
2. Double-blind cross-over clinical trial of acebutolol and propranolol in mild to moderate essential hypertension.
Pandhi P; Sethi V; Sharma BK; Wahl PL; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):606-8. PubMed ID: 3908332
[TBL] [Abstract][Full Text] [Related]
3. Metoprolol and propranolol in the treatment of essential hypertension - a long-term comparative study.
Sjöberg KH
Ann Clin Res; 1981; 13 Suppl 30():23-9. PubMed ID: 7027890
[TBL] [Abstract][Full Text] [Related]
4. Ketanserin versus propranolol in the treatment of mild and moderate essential hypertension: corroboration with ambulatory blood pressure monitoring.
Novo S; Alaimo G; Giordano U; Raineri A; Strano A
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S104-6. PubMed ID: 2446055
[TBL] [Abstract][Full Text] [Related]
5. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
Pathak L; Hiremath ; Kerkar PG; Manade VG
J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
[TBL] [Abstract][Full Text] [Related]
6. Long-term safety and efficacy of ketanserin in essential hypertension: ketanserin versus or in combination with metoprolol.
Mauersberger H
J Hypertens Suppl; 1986 Apr; 4(1):S73-5. PubMed ID: 2939217
[TBL] [Abstract][Full Text] [Related]
7. Propranolol-hydralazine combination in essential hypertension.
Stevens JD; Binstok G; Mullane JF; Woods JW; Pittman AW; del Greco F; Huang C; Morledge JH
Clin Ther; 1983; 5(5):525-39. PubMed ID: 6352036
[TBL] [Abstract][Full Text] [Related]
8. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
Lyngstam O; Rydén L
Acta Med Scand; 1981; 209(4):261-6. PubMed ID: 7015797
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of ketanserin and metoprolol in essential hypertension.
Kane JA; Tooley M; Sibbald B; Gould SE
J Hypertens Suppl; 1986 Apr; 4(1):S63-5. PubMed ID: 2939215
[TBL] [Abstract][Full Text] [Related]
10. Metoprolol in angina pectoris complicated by essential hypertension. A clinical comparison of the antianginal efficacy of metoprolol slow-release tablets (Durules) given once daily and propranolol tablets given twice daily.
BLoem TJ; Lindner PC
Ann Clin Res; 1981; 13 Suppl 30():61-7. PubMed ID: 6794420
[TBL] [Abstract][Full Text] [Related]
11. [The effects of captopril and metoprolol on blood pressure and side effects in patients with mild to moderate hypertension].
Kornerup HJ; Korsager S
Ugeskr Laeger; 1989 Apr; 151(14):890-2. PubMed ID: 2652842
[TBL] [Abstract][Full Text] [Related]
12. A double-blind comparison of spironolactone and hydrochlorothiazide in hypertensive patients treated with metoprolol.
Lavenius B; Hansson L
Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):291-5. PubMed ID: 7049966
[TBL] [Abstract][Full Text] [Related]
13. A randomized double-blind clinical trial of xipamid and hydrochlorothiazide in essential hypertension.
Kumar S; Pandhi P; Wahi PL; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1984 Oct; 22(10):549-51. PubMed ID: 6392119
[TBL] [Abstract][Full Text] [Related]
14. Verapamil SR and propranolol LA: a comparison of efficacy and side effects in the treatment of mild to moderate hypertension.
Bochsler JA; Simmons RL; Ward PJ; Chester PC; Latham AN
J Hum Hypertens; 1988 Mar; 1(4):305-10. PubMed ID: 3065507
[TBL] [Abstract][Full Text] [Related]
15. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
16. Controlled comparison of labetalol and propranolol in the management of severe hypertension.
Pugsley DJ; Armstrong BK; Nassim MA; Beilin LJ
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):777-82. PubMed ID: 791331
[TBL] [Abstract][Full Text] [Related]
17. Sustained release metoprolol: a comparison with conventional formulation in the treatment of hypertension.
Logan RL; Goldstraw PW; Kiddle GB; Flacks LM; Watt M
N Z Med J; 1981 Jul; 93(687):1-2. PubMed ID: 7022275
[TBL] [Abstract][Full Text] [Related]
18. A double-blind crossover clinical trial of labetalol and propranolol in patients of essential hypertension.
Pandhi P; Aslam S; Sharma BK; Sharma PL; Wahi PL
Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):101-4. PubMed ID: 3886563
[TBL] [Abstract][Full Text] [Related]
19. Propranolol-hydrochlorothiazide combination in essential hypertension.
Stevens JD; Mullane JF
Clin Ther; 1982; 4(6):497-509. PubMed ID: 7046937
[TBL] [Abstract][Full Text] [Related]
20. Metoprolol in high renin hypertension. A comparison with propranolol.
Lameyer LD; Hesse CJ
Ann Clin Res; 1981; 13 Suppl 30():16-22. PubMed ID: 7027889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
